has been cited by the following article(s):
[1]
|
Improving Implantation Rate in 2nd ICSI Cycle through Ovarian Stimulation with FSH and LH in GNRH Antagonist Regimen
Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics,
2021
DOI:10.1055/s-0041-1736306
|
|
|
[2]
|
Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged >=35 years: a randomized controlled trial
Human Reproduction,
2015
DOI:10.1093/humrep/dev038
|
|
|
[3]
|
Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis
Reproductive Biology and Endocrinology,
2014
DOI:10.1186/1477-7827-12-17
|
|
|